Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis

被引:12
|
作者
Tan, Shuai [1 ]
Xiao, Xiaojuan [2 ]
Ma, Hanyu [3 ]
Zhang, Zhaohui [4 ]
Chen, Jiangbo [5 ]
Ding, Lei [6 ]
Yu, Shenping [2 ]
Xu, Rulin [7 ]
Yang, Shiliang [1 ]
Huang, Xinyi [1 ]
Hong, Hua [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510080, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510080, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pancreatobiliary Surg, Guangzhou 510080, Guangdong, Peoples R China
[5] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Radiol, Guangzhou 510080, Guangdong, Peoples R China
[6] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Thorac Surg, Guangzhou 510080, Guangdong, Peoples R China
[7] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510080, Guangdong, Peoples R China
来源
PLOS ONE | 2015年 / 10卷 / 08期
关键词
TRANSIENT ISCHEMIC ATTACK; CEREBRAL INFARCTION; RECURRENCE; RISK; SURVIVAL;
D O I
10.1371/journal.pone.0135372
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and Purpose Antiplatelet therapy is widely used for the primary or secondary prevention of stroke. Drugs like clopidogrel have emerged as alternatives for traditional antiplatelet therapy, and dual therapy with clopidogrel and aspirin is of particular interest. We conducted this meta-analysis to systematically review studies about dual therapy comparing monotherapy with aspirin alone. Methods Randomized controlled trials were searched in PubMed (1966-May, 2015), EMBASE (1947-May, 2015), the Cochrane Central Register of Controlled Trials (CENTRAL) (1948-May, 2015), WHO International Clinical Trial (ICTRP) (2004-May, 2015), China Biology Medicine disc (CBM disc) (1978-May, 2015) and were included into the final analysis according to the definite inclusion criteria mentioned in the study selection section. Risk ratio (RR) was pooled with 95% confidence interval (CI) for dichotomous data. The heterogeneity was considered significant if the chi(2) test was significant (P value < 0.10) or the I-2 > 50.00%. Subgroup analyses were carried out on the long and short time periods, the race and region. Results We included 5 studies involving 24,084 patients. A pooled analysis showed that dual therapy with clopidogrel and aspirin had a lower stroke incidence than monotherapy in both the short term and long term (RR = 0.69, 95% CI: 0.59-0.82, P <0.05; RR = 0.84, 95% CI: 0.72-0.98, P = 0.03, respectively). With regard to safety, dual therapy had a higher risk of bleeding than monotherapy for both periods (RR = 1.51, 95% CI: 1.03-2.23, P = 0.04; RR = 1.54, 95% CI: 1.32-1.79, P<0.05, respectively). Conclusions Dual therapy with clopidogrel and aspirin could be a preferable choice to prevent stroke in patients who have had a previous stroke or transient ischemic attack, as well as those who are at high risk for stroke. And the effect of dual therapy seems to be more obvious for short-term. However, it is associated with a higher risk of bleeding.
引用
收藏
页数:14
相关论文
共 50 条
  • [11] Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
    Khazaei, Mojtaba
    Ghasemian, Fateme
    Mazdeh, Mehrdokht
    Taheri, Mohammad
    Ghafouri-Fard, Soudeh
    CLINICAL AND TRANSLATIONAL MEDICINE, 2019, 8
  • [12] WARFARIN VERSUS ASPIRIN FOR PREVENTION OF STROKE IN HEART FAILURE: A META-ANALYSIS
    Mehta, Kathan
    Grover, Peeyush
    Patel, Nileshkumar J.
    Shah, Neeraj
    Singh, Vikas
    Deshmukh, Abhishek
    Marzouka, George R.
    Rathod, Ankit
    Savani, Ghanshyam
    Chothani, Ankit
    Badheka, Apurva O.
    Cohen, Mauricio G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E575 - E575
  • [13] Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis
    Hao, Qiukui
    Tampi, Malavika
    O'Donnell, Martin
    Foroutan, Farid
    Siemieniuk, Reed A. C.
    Guyatt, Gordon
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [14] Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA - A meta-analysis
    Verro, Piero
    Gorelick, Phillip B.
    Nguyen, Danh
    STROKE, 2008, 39 (04) : 1358 - 1363
  • [15] Clopidogrel Versus Aspirin for Long-Term Secondary Prevention of Atherosclerosis: A Meta-Analysis
    Al-Abdouh, Ahmad
    Abusnina, Waiel
    Mhanna, Mohammed
    Radaideh, Qais
    Jabri, Ahmad
    Abu Rmilah, Anan
    Alzu'bi, Hossam
    Barbarawi, Mahmoud
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (19) : B154 - B155
  • [16] Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis
    Lin, Michelle P.
    Meschia, James F.
    Gopal, Neethu
    Barrett, Kevin M.
    Ross, Owen A.
    Ertekin-Taner, Nilufer
    Brott, Thomas G.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (03):
  • [17] Cilostazol versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis
    Lin, Michelle P.
    Barrett, Kevin M.
    Meschia, James F.
    Eidelman, Benjamin H.
    Huang, Josephine F.
    Brott, Thomas G.
    STROKE, 2020, 51
  • [18] Efficacy and safety of ticagrelor versus aspirin and clopidogrel for stroke prevention in patients with vascular disease: a systematic review and meta-analysis
    Ma, Xibo
    Li, Danfeng
    Liu, Shihua
    Chen, Yan
    Zhong, Ping
    EUROPEAN NEUROLOGY, 2023, 86 (04) : 229 - 241
  • [19] CLOPIDOGREL AND ASPIRIN VERSUS ASPIRIN ALONE IN HIGH-RISK PATIENTS WITH ESTABLISHED VASCULAR DISEASE; A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Kamireddy, Swapna
    Sabatine, Marc S.
    Bhatt, Deepak L.
    Steinhubl, Steven R.
    Boden, William E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [20] Aspirin and Clopidogrel for Prevention of Ischemic Stroke
    Ruth M. Thomson
    David C. Anderson
    Current Neurology and Neuroscience Reports, 2013, 13